WELCOME TO THE BRITISH ASSOCIATION FOR THE STUDY OF THE LIVER
6th - 9th October
ICC Wales
BASL2026 is supported by sponsors including pharmaceutical companies - a full declaration and list of sponsors can be found
BASL ANNUAL MEETING
6th-9th October 2026
BASL ANNUAL MEETING 2026 -
Tuesday 6th - Friday 9th October - including: BLTG Transplant Meeting and BLNA Nurse meeting.
International Convention Centre, Newport, Wales.
Abstract submission deadline extended to 12pm 12th June!
Full details here:
BASL ANNUAL MEETING
BLNA
MEETING
BLTG
MEETING
BASL AND BASL SUB-GROUPS
 |
The British Association for the Study of the Liver is a multi-disciplinary society with around 900 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions. |
 |
British Liver Nurses' Association is a professional nursing organisation aiming to develop knowledge and understanding of liver disease, in order to improve the quality of patient care. |
 |
The British Viral Hepatitis Group aims to improve 糖心logo and study of patients with chronic viral liver disease, bringing together UK hepatologists, gastroenterologists, infectious disease physicians, virologists and interested epidemiologists. |
 |
The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development. The BLTG will foster close relationships with BTS (British Transplant Society) and LICAGE (Liver Intensive Care Group of Europe) and will build on the role of the UK and Ireland Annual Meeting by delivering structure and authority to the group. |
 |
Is a professional pharmacy organisation aiming to develop knowledge and understanding of liver disorders including viral hepatitis, in order to improve the quality of patient care, through medicines optimisation, collaborative and multi-disciplinary working and promoting patient-focused research. |
 |
British Association for Allied Health Professionals in Liver is a professional group for AHP’s specialising or working with patients with liver conditions. Bringing together specialist hepatology AHP’s from across the four Nations. Their aim is to promote excellence through the provision of AHP care to all patients with liver disorders. |
News
Save the Date: North vs South UK Cricket Match Sunday 12th July
Read moreNorth vs South cricket match, raising funds for the British Liver Trust
Sunday 12th July 2026, York Cricket Club, York
11:00 – 16:00 (time TBC)
All Welcome!
Tombola/Raffle/stalls
If you wish to play for the North please contact Dr Joanna Moore (Joanna.moore@nhs.net)
If you wish to play for the South please contact Dr Gautam Mehta (gautam.mehta@ucl.ac.uk )
Gilead UK & Ireland 2026 Viral Hepatitis and BBV Testing Fellowship and Medical Grants Programme is now open
Read moreOn behalf of Gilead Sciences Ltd.
The鈥疓ilead UK & Ireland Viral Hepatitis and BBV Testing Fellowship and Medical Grants Programme鈥痜unds innovative projects and initiatives that can ultimately lead to an improvement in awareness and diagnosis of viral hepatitis (B, C and Delta) and/or demonstrate the proof of concept/pilot Opt-Out testing of BBV (HBV, HCV, HDV and HIV).
Applications are invited from healthcare and third sector organisations (e.g., charities) who are seeking funding for a project that aligns with the goals of the programme. Please be advised that only health-related organisations are eligible to receive grants through this application process. Individual applicants are not eligible for funding.
The programme is looking to support innovative projects and initiatives that:
- Improve awareness and diagnosis鈥痮f viral hepatitis (B, C, and Delta), including among migrant and other underserved communities
- Demonstrate proof of concept and/or pilot opt-out BBV testing鈥�across a broader range of healthcare and community settings where high prevalence rates of HBV, HCV, HDV and HIV are expected (e.g., primary care, women’s health hubs, psychiatry services, migrant health services, and services targeting underserved populations)
- Optimise linkage to care and/or management鈥痜or people living with viral hepatitis (B, C, and Delta), including peer support
- Evaluate innovative approaches鈥痶o optimising patient pathways and enabling rapid access to care for those newly diagnosed with viral hepatitis (B, C, and Delta)
- Enhance patient support programmes and tools鈥痜or people living with viral hepatitis (B, C, and Delta), with a focus on addressing stigma, community outreach and engagement, disease awareness, and prevention of transmission
- Improve understanding of, and reduce, variations in care鈥痜or people living with viral hepatitis (B, C, and Delta), and improve the experiences of people from marginalised communities
- Improve the use of data鈥�to diagnose people with viral hepatitis (B, C, and Delta) and to identify those lost to follow-up
- Assess the societal and health economic implications鈥痮f hepatitis B and Delta
The application window will close on鈥�Friday 22nd May 2026. More information about the Gilead UK & Ireland Viral Hepatitis and BBV Testing Fellowship and Medical Grants Programme, is available on the鈥疓ilead UK and Ireland website > .
Any questions regarding the process or the application form can be directed to鈥�gileadfellowship@axon-com.com .
Date of prepartion: April 2026
Code: UKI-UNB-2707
Optimizing Multidisciplinary Team (MDT) Working in Hepatobiliary (HB) Oncology Survey
Read moreThis survey is intended for clinicians and allied health care professionals to help inform current provision of MDT practice in the UK and ultimately to inform best practice. The purpose of the project is intended predominantly to apply to HB cancer MDTs, although other forms of MDT and cancer MDTs may be touched on. It intends to map current practice and attitudes to HB cancer MDTs. More importantly it aims to identify inequalities in access to care and expertise and to provide universal standards that can be applied across the NHS and perhaps wider healthcare systems.
The survey will be derived from UK MDT centres whilst a separate Delphi process will be generated through a multi-disciplinary body of experts (medical, nursing, AHPs) across the specialties, and also patients and patient groups and charities. As an endpoint, the working group wants their findings to be published in a peer-reviewed journal and to be disseminated to National bodies, e.g. NHS bodies in England, Northern Ireland, Scotland and Wales, along with Cancer alliances and NHS trusts.
Please complete the survey and forward it to other members of your MDT, including surgeons, medical and clinical oncologists, clinical nurse specialists, radiologists (diagnostic and interventional), histopathologists, gastroenterologists, hepatologists and other allied health professionals who are involved in HB care.
The survey may take 10-15 minutes to complete but it is important we get as many responses as possible so completion would be appreciated.
Survey link:
The closing date for completion of the survey is 3rd June 2026.
Contact admin@basl.org.uk for any questions.
Thank you for taking part.
Kind regards,
Tim Cross
Past President BASL
BASL Special Interest Group (SIG) Lead Nominations Round Open
Read moreBASL is seeking nominations for a number of Special Interest Group (SIG) Leads as the current leads have come to the end of their tenure. These SIGs are linked to the NIHR’s Research Delivery Network (RDN) topic areas.
SIG Leads will serve for two years and the posts currently up for change are as listed below:
- Acute Liver Failure (ALF) SIG
- Alcohol related Liver Disease (ArLD) SIG
- Cholangiocarcinoma-UK (CCA-UK) SIG
- Immune-Mediated Liver Disease SIG
- Metabolic Dysfunction–Associated Liver Disease (MASLD) SIG
- Palliative Hepatology SIG
- Portal Hypertension SIG
- Rare Diseases SIG
NB: SIG Leads are required to be a BASL member.
Further information for each of the SIGs may be found on the BASL website HERE
The role of the SIG Lead can be found in the BASL/BSG Special Interest Groups (SIGs) Terms of Reference
Eligibility requirements
- Candidates wishing to be considered for nomination must be a BASL member or a member of the relevant SIG their nomination is for.
- Each candidate must have a proposer and seconder, who should also be a BASL member or an associate member through the relevant SIG.
Nomination process
- Please send nominations by email clearly stating the SIG Lead position that your nomination is for to the BASL Secretariat at sigs@basl.org.uk by 17:00 on 12th May 2026.
- Candidates wishing to be considered for nomination must be a member of BASL and will require one BASL / SIG member to propose them and a second BASL / SIG member to second their nomination.
- If only one candidate is proposed and seconded, that candidate will be elected unopposed as the appropriate SIG Lead.
- If two or more candidates are nominated, eligible candidates will be asked to submit a personal statement of up to 300 words. The Secretariat will then arrange for an election where members of the appropriate SIG will be invited to vote.
- The successful candidate/s will be elected by a simple majority of those members voting to the appropriate SIG Lead post.
BASL is committed to promoting equality, diversity and inclusion in all aspects of its work. It is actively promoting equal opportunities and access for all our members regardless of their background. We would, therefore, encourage you to consider this role to help shape the future of BASL and increase our inclusivity/inclusiveness.
Please contact sigs@basl.org.uk if you require any further information.
National Clinical Impact Awards 2026 - application deadline 5pm 20th May
Read moreThe National Clinical Impact Awards 2026 round opened on 1st April 2026.
The application window will remain open for seven weeks, closing at 17:00 on 20th May 2026.
Guidance for the 2026 National Clinical Impact Awards has been published here>
A short guide for applicants can be found HERE.
Events
BVHG are happy to be a non-financial endorser of the European Meeting on HIV & Hepatitis 2026.
Founded more than twenty years ago as the European HIV Resistance Workshop, the European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance has evolved to embrace all aspects of the clinical care of people living with HIV in Europe. This workshop places emphasis in particular on optimal treatment strategies, clinical virology, molecular epidemiology, and public health aspects of HIV, HBV, HCV, as well as emerging viruses throughout Europe.
Meeting Details:
Date: 10-12 June 2026
Format: in-person (no virtual option available)
Location: Barcelona, Spain
Venue: NH Collection Barcelona Constanza
For more information on how to register for the meeting visit the event website HERE:
Registration:
Registration link:
BASL members can claim a discount of 25% on their registration.
Enter discount code: EMHH26BASL25 when booking.
A special two-day event marking six decades of pioneering liver services at King’s College Hospital
Date: 11th June arrival from 12:30-1:00PM / 12th June arrival from 8:30-9.00AM
Venue: Fetal Medicine Research Institute
Address: 16-20 Windsor Walk, Denmark Hill, London, SE5 8BB
King’s College Hospital has been driving world-leading liver science since the 1960s. In 2026, they mark a key milestone: 60 years since the establishment of the world-renowned Institute of Liver Studies at the hospital. This one off event will bring together leading clinicians, researchers and industry partners to reflect on progress – and to look ahead to the future of liver science.
How To Register
You must register in advance for this event, please use the link below to secure your place. This will be a CPD accredited event.
View the Programme and Register via the event website here; .
This is a free event but a Refundable Deposit is Required.
Guests will also attend a special anniversary dinner at Dulwich Picture Gallery on Day 1, bringing together the people who've shaped liver services at King’s across six decades.
Save the Date
MASLD Virtual SIG Meeting
Date: Friday 12th June
Time: 2.30pm to 4pm
Agenda:
- Reflections on recent MASLD SIG activities
- Pharmacotherapies for MASH- current status of agents under consideration by regulatory bodies
- Future plans for the SIG
Registration Open - Register>
Open to BASL Members and SIG Members.
17/06/26
BASL School of Hepatology Webinar Series
We are delighted to announce the next webinar in our 2026 series:-
Title: “Autoimmune Hepatitis.. yes, it is sometimes difficult”
Date: Wednesday 17th June
Time: 19:00-20:00 UK
Speaker: Professor Dermot Gleeson
Format - a talk followed by a Q&A session
Platform - Zoom
FREE to attend for BASL Members and non-members. Catch up recording will only be available to BASL members.
You can read the BASL Events Data Protection Disclaimer via this link before registering:
Contact: kim@basl.org.uk for any questions
BASL School of Hepatology Webinar Series is supported by sponsors including pharmaceutical companies. Pharmaceutical companies have solely provided financial sponsorship, with no input into the arrangements or agenda of the meeting. A full list of sponsors can be found below:
Registration is now open for the BSG Annual Meeting BSG LIVE'26, taking place 22 - 25 June 2026 at the ACC in Liverpool.
You can attend in-person, or virtually which provides you with access to 3 full live streams from the Tuesday to the Thursday of the conference, e-poster and on-demand content access.
This is a must-attend event for all healthcare professionals working in gastroenterology and hepatology, featuring:
Interactive Symposiums - covering all aspects of gastroenterology including dozens of CPD accredited sessions
Plenary Session - inspiring and thought-provoking sessions lead by experts in the speciality
Industry Lead Sessions - including an interactive exhibition where you can discover the latest developments in the industry
Scientific Poster Gallery - discover the latest research and clinical advances in gastroenterology including Flash Poster
Presentations taking place each lunchtime on a bank of mini stages
EndoVillage - open over 2 days where you can gain hands-on one-to-one training for an introduction to different endoscopic scenarios
Hybrid and On-Demand Content Library - take part in a number of parallel streams available to watch live throughout 3 days and 70+ hours of high-quality educational content available to watch on-demand
Make sure you secure your place before 27 April 2026 in order to save with the discounted early bird rate. You can register at
This year's programme flatplan is now available to view here: